良性前列腺增生。医学及微创治疗方案。 - Suppr

Suppr

超能文献

Benign prostatic hyperplasia. Medical and minimally invasive treatment options.

作者信息

Oesterling J E

出版信息

N Engl J Med. 1995 Jan 12;332(2):99-109. doi: 10.1056/NEJM199501123320207.

DOI:10.1056/NEJM199501123320207

PMID:7527494

Abstract

摘要

相似文献

Benign prostatic hyperplasia. Medical and minimally invasive treatment options.

N Engl J Med. 1995 Jan 12;332(2):99-109. doi: 10.1056/NEJM199501123320207.

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

N Engl J Med. 1996 Aug 22;335(8):533-9. doi: 10.1056/NEJM199608223350801.

Treatment options for benign prostatic hyperplasia.

Can Fam Physician. 1997 Aug;43:1395-404.

Treatment of benign prostatic hyperplasia.

N Engl J Med. 1996 Aug 22;335(8):586-7. doi: 10.1056/NEJM199608223350809.

Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.

Ir Med J. 1996 May-Jun;89(3):86, 88.

Benign prostatic hyperplasia. New concepts in the 1990s.

Postgrad Med. 1993 Nov 1;94(6):141-6, 151-2.

[Drugs against symptomatic, benign prostatic hyperplasia].

Tidsskr Nor Laegeforen. 2002 Oct 30;122(26):2544-5.

[Treatment of benign prostatic hypertrophy].

Orv Hetil. 2003 Nov 9;144(45):2229-30.

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.

Benign prostatic hyperplasia. Age and type of treatment.

J Urol (Paris). 1995;101(1):50-2.

引用本文的文献

Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.

Am J Mens Health. 2020 Mar-Apr;14(2):1557988320905407. doi: 10.1177/1557988320905407.

Double-parabolic-reflectors acoustic waveguides for high-power medical ultrasound.

Sci Rep. 2019 Dec 6;9(1):18493. doi: 10.1038/s41598-019-54916-2.

Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?

Nutr Metab Insights. 2018 May 8;11:1178638818773072. doi: 10.1177/1178638818773072. eCollection 2018.

Outcome analysis of transurethral resection versus potassium titanyl phosphate-photo selective vaporization of the prostate for the treatment of benign prostatic hyperplasia; a randomized controlled trial with 4 years follow up.

Turk J Urol. 2017 Jun;43(2):176-182. doi: 10.5152/tud.2017.20586. Epub 2017 Apr 18.

Does caval aorta index correlate with central venous pressure in intravascular volume assessment in patients undergoing endoscopic transuretheral resection of prostate?

Saudi J Anaesth. 2016 Apr-Jun;10(2):174-8. doi: 10.4103/1658-354X.168062.

Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.

J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1262-8. doi: 10.1093/gerona/glv051. Epub 2015 Apr 28.

Ropivacaine: Anesthetic consideration in elderly patients for transurethral resection of prostrate a clinical trial.

Anesth Essays Res. 2013 May-Aug;7(2):178-82. doi: 10.4103/0259-1162.118950.

Clinical outcome in male patients with detrusor overactivity with impaired contractility.

Int Neurourol J. 2014 Sep;18(3):133-7. doi: 10.5213/inj.2014.18.3.133. Epub 2014 Sep 24.

Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.

Curr Ther Res Clin Exp. 2004 Nov;65(6):505-14. doi: 10.1016/j.curtheres.2005.01.001.

Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.

ScientificWorldJournal. 2012;2012:463574. doi: 10.1100/2012/463574. Epub 2012 Sep 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验